These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931 [TBL] [Abstract][Full Text] [Related]
4. The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat. Kimura RE; Dy SA; Uhing MR; Beno DW; Jiyamapa VA; Lloyd-Still JD J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):178-83. PubMed ID: 10435655 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125 [TBL] [Abstract][Full Text] [Related]
12. Comparative and experimental pathology of fibrosing colonopathy. van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182 [TBL] [Abstract][Full Text] [Related]
13. Fibrosing colonopathy in children with cystic fibrosis. Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129 [TBL] [Abstract][Full Text] [Related]
14. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy. Mack EH; Brett AS; Brown D South Med J; 2004 Sep; 97(9):901-4. PubMed ID: 15455984 [TBL] [Abstract][Full Text] [Related]
15. Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosis. Leblond FA; Morisset J; LeBel D Pediatr Res; 1989 May; 25(5):478-81. PubMed ID: 2717264 [TBL] [Abstract][Full Text] [Related]
17. Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat. Sigthorsson G; Jacob M; Wrigglesworth J; Somasundaram S; Tavares I; Foster R; Roseth A; Rafi S; Mahmud T; Simpson R; Bjarnason I Scand J Gastroenterol; 1998 Jul; 33(7):728-35. PubMed ID: 9712237 [TBL] [Abstract][Full Text] [Related]
18. Fibrosing colonopathy in children with cystic fibrosis. Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179 [No Abstract] [Full Text] [Related]